Publications by authors named "N B Cinar"

Background: Rigicon is a newer inflatable penile prostheses (IPP) manufacturer that has produced the Infla10 IPP for countries outside the United States (US) since 2019, with Food and Drug Administration studies for approval of Infla10 in the US presently underway.

Aim: This study aims to report the first patient satisfaction, efficacy, and safety from revision data for the newly available Rigicon Infla10 IPP.

Methods: A single surgeon's first 58 patients who underwent Rigicon Infla10 IPP implantation between 2019 and 2023 were included.

View Article and Find Full Text PDF

Aim: This study aimed to investigate the relationship between electrophysiological findings of diabetic neuropathy (DN) and patients' quality of life, neuropathic pain levels, and well-being.

Materials And Methods: A cross-sectional study was conducted in 12 centers in Turkey. DN patients were categorized into four stages based on electrophysiological findings using the Baba classification.

View Article and Find Full Text PDF

The General Practitioner Assessment of Cognition (GPCOG) was explicitly developed as a brief cognitive screening tool for general practitioners. It consists of a patient section testing cognition and an informant section asking historical questions. This study aimed to test the validity and reliability of the Turkish version of GPCOG-Tr on older Turkish adults.

View Article and Find Full Text PDF

Background: The incidence of Hepatitis A is increasing worldwide. Yearly classification of Hepatitis A Seroprevalence for different times in different regions of Türkiye allows indirect measurement of year-specific incidence rates of HAV infection and can be considered the best way to define Hepatitis A status. This study aimed to examine the change in the incidence of hepatitis A by systematically evaluating the available data on the seroprevalence of anti-HAV antibodies in the Turkish population.

View Article and Find Full Text PDF
Article Synopsis
  • The study compares the pain and fear levels associated with intramuscular injections in children aged 4 to 6 years at two different injection sites: the vastus lateralis and the ventrogluteal.
  • A randomized trial design involved 43 children receiving injections at the ventrogluteal site and 40 at the vastus lateralis site, measuring fear and pain through specific scales and the duration of crying during the procedure.
  • Results indicated that children injected in the ventrogluteal site experienced significantly less fear, pain, and crying time compared to those who received injections in the vastus lateralis site.
View Article and Find Full Text PDF